An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents.

Source:http://linkedlifedata.com/resource/pubmed/id/12912950

Clin. Cancer Res. 2003 Aug 1 9 8 3012-20

Download in:

View as

General Info

PMID
12912950